Overcoming Tumor Heterogeneity via Multispecific Targeting
Time: 9:00 am
day: Day Two
Details:
- Scientific rationale for TwoStep Therapeutics’ multi-specific targeting agent “PIP” and how it enables broad applicability across solid tumors
- Overview of the PIP targeting platform, featuring modular formats with tunable PK and compatibility with diverse payloads
- Preclinical development of PIP-drug conjugates, their efficacy and safety, and comparison to conventional single-antigen targeting approaches
